Search for: "IN RE WYETH"
Results 481 - 500
of 702
Sorted by Relevance
|
Sort by Date
13 Jul 2011, 3:04 am
(BIOtechNOW) US: PTO agrees to reexamine broad codon-optimization patents (Holman’s Biotech IP Blog) US: Inherently incomprehensible: Does the CAFC’s view of inherency in In Re Kao spell the end of second medical use patents in the USA? [read post]
8 May 2012, 5:59 pm
Supreme Court’s pro-preemption Mensing decision is inapplicable and a court should instead employ the preemption analysis utilized in the Court’s decision in Wyeth v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
2 Jun 2010, 12:42 pm
Supreme Court’s 2009 decision in Wyeth v. [read post]
11 Dec 2009, 5:00 am
Wyeth, Inc., 85 Cal.Rptr.3d 299 (Cal. [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog) Ruminations on the… [read post]
14 Jun 2013, 12:13 pm
Wyeth, Inc., 686 F.3d 618, 622 n.5 (8th Cir. 2012), rev’g, In re Prempro Prods. [read post]
29 Mar 2007, 4:46 am
Wyeth Labs., Inc., 161 N.J. 1, 25 (1999). [read post]
27 May 2010, 3:20 am
(Patent Docs) Cipro (Ciprofloxacin)- Cipro patent settlement case appealed to the California Court of Appeal: In re Ciprofloxacin Antitrust Litigation (FDA Law Blog) (Patent Docs) Fluvastatin - Spain: Interim injunctive relief in Spain – Novartis (PatLit) Intuniv (Guanfacine) – US: Patent infringement complaint based on ANDA filing: Shire LLC et al. v. [read post]
1 Feb 2007, 6:07 am
Wyeth Laboratories, Inc., 1362 N.W.2d 293, 296-97 (Mich. [read post]
31 Dec 2015, 5:12 am
Full disclosure: Reed Smith is involved in Caplinger, so consider this entry a non-RS post.In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015). [read post]
1 May 2008, 11:21 am
One of the ways we feed this blog is doing what comes naturally to us lawyers - reading recent cases - and hoping that something inspires us. [read post]
28 Oct 2015, 4:30 am
In Re Risperdal Litigation, 2015 Phila. [read post]
5 Sep 2018, 11:46 am
” Google’s plans to re-enter the Chinese market, codenamed Dragonfly, were leaked by an employee to the Intercept last month. [read post]
5 Sep 2018, 11:46 am
” Google’s plans to re-enter the Chinese market, codenamed Dragonfly, were leaked by an employee to the Intercept last month. [read post]
18 Jun 2015, 1:00 pm
Wyeth, 85 A.3d 434 (Pa. 2014), for proposition that negligence is the only allowed design-related product liability theory). [read post]
8 Jul 2012, 10:58 am
In re Viagra Prods., 572 F. [read post]
19 Apr 2013, 5:35 pm
Wyeth Pharm. [read post]
15 Nov 2013, 11:34 am
In re Schering Plo [read post]
